Part I: Tumor markers from A to Z

ADLM survey finds that FDA’s final laboratory developed tests rule will hinder patient care for underserved communities

Mayo Clinic study finds dysfunctional white blood cells linked to heightened melanoma risk

Integrated DNA launches new Archer HRD technology for cancer research

AABB publishes Guide to Informed Consent in Transfusion Medicine

Youth e-cigarette use drops to lowest level in a decade